Literature DB >> 8542484

Association of out-of-hospital criteria with need for hospital admission.

J L Burstein1, J E Hollander, M C Henry, R Delagi, H C Thode.   

Abstract

OBJECTIVE: To validate high-risk historical and physiologic out-of-hospital criteria as predictors of the need for hospitalization following ED evaluation.
METHODS: Consecutive patients entered into the Suffolk County advanced life support system were enrolled. Previously proposed historical and physiologic "high-risk" criteria for hospitalization were prospectively collected. Criteria were associated with the need for hospital admission following ED evaluation.
RESULTS: 1,238 patients were enrolled; 391 were released from an ED after transport. Most patients (843/1,238; 68%) were admitted to a hospital; and four died in the ED. Factors associated with an increased likelihood of admission or death among the transported patients were: bradycardia (90% admitted, p < 0.02); hypotension (80%, p < 0.03); hypertension (89%, p < 0.03); and age > 55 years (81%, p < 0.0001). Unresponsiveness and other abnormal vital signs were not associated with admission on univariate analysis. Logistic regression analysis identified two other factors associated with admission or death: tachycardia (72% admitted, p < 0.01) and head injury (78% admitted, p < 0.001).
CONCLUSIONS: Abnormal pulse or blood pressure, head injury, and age > 55 years are associated with patients' requiring hospital admission after accessing the emergency medical services system. These criteria may aid the design of out-of-hospital refusal-of-care policies.

Entities:  

Mesh:

Year:  1995        PMID: 8542484     DOI: 10.1111/j.1553-2712.1995.tb03098.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  1 in total

1.  Effect of advanced age and vital signs on admission from an ED observation unit.

Authors:  Jeffrey M Caterino; Emily M Hoover; Mark G Moseley
Journal:  Am J Emerg Med       Date:  2012-03-03       Impact factor: 2.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.